GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » U2Bio Co Ltd (XKRX:221800) » Definitions » Short-Term Debt

U2Bio Co (XKRX:221800) Short-Term Debt : ₩0 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is U2Bio Co Short-Term Debt?

U2Bio Co's Short-Term Debt for the quarter that ended in Dec. 2023 was ₩0 Mil.

U2Bio Co's annual Short-Term Debt declined from Dec. 2021 (₩1,600 Mil) to Dec. 2022 (₩0 Mil) but then stayed the same from Dec. 2022 (₩0 Mil) to Dec. 2023 (₩0 Mil).


U2Bio Co Short-Term Debt Historical Data

The historical data trend for U2Bio Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

U2Bio Co Short-Term Debt Chart

U2Bio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only 1,700.00 7,270.26 1,600.00 - -

U2Bio Co Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Short-Term Debt - - - -

U2Bio Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


U2Bio Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of U2Bio Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


U2Bio Co (XKRX:221800) Business Description

Traded in Other Exchanges
N/A
Address
Basement 1, 68 Gumaro Songpagu, Seoul, KOR
U2Bio Co Ltd provides vitro diagnostic test services. The company is engaged in offering general diagnostic tests, molecular diagnostic tests, and breastfeeding nutritional analysis services among others.

U2Bio Co (XKRX:221800) Headlines

No Headlines